Search results for: 'oncology case t 221b 45 phase ii or lucenc'

Did you mean: oncology case t 221b 45 phase ii or licens

Related search terms: 221b data alliance review; oncology partnering 2019 2025; case 27s diseases partnering 2016 2020; case partnering 2016 2025; oncology case t 221b 45 phase ii or licens

Cancer Monoclonal Antibody Collaboration and Licensing Deals 2016-2025
November 2025

$3,995.00

Add to Wish List Add to Compare

Cancer Monoclonal Antibody Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2025
Learn More
Molecular Diagnostics for Infectious Disease: Market Forecasts by Syndrome, Plex, Place and Country with Analysis and Executive Guides 2025-2029
January 2025

$6,995.00

Add to Wish List Add to Compare

Infectious Disease Molecular Diagnostics (MDx) Markets | Global coverage | Market size | Actionable insights| Trends | Key companies | Growth forecasts
Learn More
Respiratory Infection Diagnostics: Market Forecasts by Technology, Plex, Place and Country with Analysis and Executive Guides 2025-2029
January 2025

$6,995.00

Add to Wish List Add to Compare

Respiratory Infection Diagnostics Markets | Global coverage | Market size | Actionable insights| Trends | Key companies | Growth forecasts
Learn More
Sepsis Diagnostics: Market Forecasts by Assay, Cause, Product, Place and Country with Analysis and Executive Guides 2025-2029
January 2025

$6,995.00

Add to Wish List Add to Compare

Sepsis Diagnostics Markets | Global coverage | Market size | Actionable insights| Trends | Key companies | Growth forecasts
Learn More
Syndromic Multiplex Diagnostics: Strategies and Trends, Market Forecasts by Syndrome, Place, Product and Country with Analysis and Executive Guides 2025-2029
January 2025

$6,995.00

Add to Wish List Add to Compare

Syndromic Multiplex Diagnostics Markets | Global coverage | Market size | Actionable insights| Trends | Key companies | Growth forecasts
Learn More
Collaboration Deals in Biotechnology 2020-2026
March 2026

$4,995.00

Add to Wish List Add to Compare

Collaboration Deals in Biotechnology | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2020 to 2026
Learn More
Ophthalmics Collaboration and Licensing Deals 2019-2025
October 2025

$3,995.00

Add to Wish List Add to Compare

Ophthalmics Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals | Comprehensive deal directory 2019 to 2025
Learn More
Cancer Diagnostic Collaboration and Licensing Deals 2018-2025
November 2025

$3,995.00

Add to Wish List Add to Compare

Cancer Diagnostic Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2018 to 2025
Learn More
Cardiovascular Collaboration and Licensing Deals 2016-2026
April 2026

$3,995.00

Add to Wish List Add to Compare

Cardiovascular Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals | Comprehensive deal directory 2016 to 2026
Learn More
Gene Editing Collaboration and Licensing Deals 2016-2025
November 2025

$3,995.00

Add to Wish List Add to Compare

Gene Editing Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2025
Learn More